The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Clinical · Special populations

Type 1 diabetes: off-label use and the evidence gap

Solved
Solved by f.villalobos in post #2
I read the opening post twice before replying, because I had assumed the opposite. Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose reduction and close monitoring for hypoglycemia. This is manageable with attention.

Jump to the accepted answer →

SV
sa.vogelTL2 Moderator5 Jul 2026#1

On the subject in the title: Type 1 diabetes: off-label use and the evidence gap Working notes rather than a conclusion.

General question, not a request for advice about my own care — I know the difference and I would rather be told to see my prescriber than get an answer that pretends otherwise.

I have a panel in front of me with one value outside the reference interval and everything else within it. My instinct is that a single out-of-range result on a single draw is close to uninformative, and I would like to understand how the people who read these professionally think about that.

What I am actually asking is how to tell an interesting result from an uninteresting one before booking an appointment about it.

41 likes 23d
FV
f.villalobosTL2 Moderator Solution17 Jul 2026#2

I read the opening post twice before replying, because I had assumed the opposite.

Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose reduction and close monitoring for hypoglycemia. This is manageable with attention.

7 likes 10d
CL
c.lundgrenTL2 Moderator27 Jul 2026#3

Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings in rodent toxicology. The history (personal or family, especially multiple endocrine neoplasia type 2) is an important screening question.

1 like 1d

Suggested topics

TopicParticipantsRepliesViewsActivity
Older adults, sarcopenia risk, and the trade-off nobody quantifies
Older adults, sarcopenia risk, and the trade-off nobody quantifies — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a person. The published…
VJSATYAJR+103 109 12k 5mo
Type 1 diabetes: off-label use and the evidence gap — what changed since
Type 1 diabetes: off-label use and the evidence gap — what changed since — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a person. The…
SOKRZSNTSD+68 77 31k 20mo
Renal impairment: what the labelling says about dose
On the subject in the title: Renal impairment: what the labelling says about dose Working notes rather than a conclusion. General question, not a request for advice about my own care — I know the difference…
OVJPZOFKJB 4 8.9k 19mo
[2026 update] People with a low starting BMI: where the evidence stops
People with a low starting BMI: where the evidence stops Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The published…
VBGPKBCRMG+19 23 62k 23mo
Coming back to: Renal impairment: what the labelling says about dose
Renal impairment: what the labelling says about dose — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a person. The published trials in this…
NGDBCTJROF+30 34 48k 18mo

Related topics — sharing the tags pregnancy & planning, bariatric surgery history, disordered eating

TopicParticipantsRepliesViewsActivity
Mood changes: monitoring, and when to involve a professional
Mood changes: monitoring, and when to involve a professional — setting out what I have, and where I think it stops being reliable. General question, not a request for advice about my own care — I know the…
CGALGV 2 362 13mo
Food noise reducing and the disorientation that can follow
Posting this under the heading it deserves: Food noise reducing and the disorientation that can follow Everything below is what sits behind that. General question, not a request for advice about my own care —…
JWKACCJFV+40 45 8.9k 20mo
Absolute versus relative contraindications
On the subject in the title: Absolute versus relative contraindications Working notes rather than a conclusion. General question, not a request for advice about my own care — I know the difference and I would…
HNBRMALFN+4 8 23k 8mo
About the Contraindications category
Absolute and relative contraindications, and the conditions that change the calculus. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its…
TVSLETKFCC+6 10 35k 14mo
Talking to a therapist about this specifically — does this still hold?
The question in the title: Talking to a therapist about this specifically — does this still hold? I will give what I have already checked below so nobody repeats it. Asking about a population rather than…
POAABFPMDB+59 65 13k 14mo